Device for the electronic and electrochemical measurement of analyte concentrations in biological samples
US-2024219386-A1 · Jul 4, 2024 · US
US2025035581A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025035581-A1 |
| Application number | US-202218714512-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 30, 2022 |
| Priority date | Dec 1, 2021 |
| Publication date | Jan 30, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A biosensor includes a multiplexed array of electrolyte-gated functionalized field effect transistors (FET). Walls fluidically separate each of the FETs from one another provide wells corresponding to each channel of the FETS. A perimeter wall on the upper surface of the multiplex array surrounding the separating walls and traversing the surface of all FETS in the multiplexed array. The perimeter forms a fluidically tight well traversing multiple ones of the FETs. Each of the FETs includes monolayer of a two dimensional material, such as graphene, as a conducting channel, wherein each conducting channel functionalized according to a predetermined agent.
Opening claim text (preview).
1 . A biosensor comprising: a multiplexed array of electrolyte-gated field effect transistors (FET); separating walls on an upper surface of the multiplexed array, the walls fluidically separating each of the FETs from one another; and a perimeter wall on the upper surface of the multiplexed array surrounding the separating walls and traversing the surface of all FETS in the multiplexed array, the perimeter wall forming a fluidically tight well traversing multiple ones of the FETs, the fluidically sealed well subdivided into a plurality of chambers, each chamber corresponding to one of the FETs in the multiplexed array; wherein each FET comprises monolayer of a two dimensional (2D) material as a conducting channel, wherein each conducting channel functionalized according to a predetermined agent. 2 . The biosensor of claim 1 , wherein height of the separating walls is less than height of the perimeter wall. 3 . The biosensor of claim 1 , further comprising an electrolyte in the well. 4 . The biosensor of claim 3 , wherein the electrolyte is one of or a combination of phosphate buffered saline, Hanks' Balanced Salt Solution, Tris, Saliva, nasal swab dissolved in DI water or the like. 5 . The biosensor of claim 1 , wherein the separating walls comprise a polymer. 6 . The biosensor of claim 1 , wherein the separating walls comprise polydimethylsilixane, EcoFlex, SU-8, PMMA, a combination thereof or the like. 7 . The biosensor of claim 1 , wherein the separating walls comprise SiO2/Si, sapphire, glass, SiC, and flexible polyimides, parylene, polyester, tape, polycarbonate, Teflon, PET, EVA/PET. 8 . The biosensor of claim 1 , wherein the perimeter wall comprises a polymer. 9 . The biosensor of any one of claim 1 , wherein the perimeter wall comprises polydimethylsilixane, EcoFlex, SU-8, PMMA, a combination thereof or the like. 10 . The biosensor of claim 1 , wherein the perimeter wall comprises SiO2/Si, sapphire, glass, SiC, and flexible polyimides, parylene, polyester, tape, polycarbonate, Teflon, PET, EVA/PET, or the like. 11 . The biosensor of claim 1 , wherein at least one of the predetermined agents is a control. 12 . The biosensor of claim 1 , wherein at least one of the predetermined agents is flu antibody. 13 . The biosensor of claim 1 , wherein at least one of the predetermined agents is a COVID antibody. 14 . The biosensor of claim 1 , wherein at least one of the predetermined agents is an anti-ferritin antibody. 15 . The biosensor of claim 1 , wherein at least two of the FETs are functionalized differently. 16 . The biosensor of claim 1 , wherein the multiplexed array comprises an n×m array of FETs. 17 . The biosensor of claim 14 , wherein n=m. 18 . The biosensor of claim 1 , wherein the multiplexed array comprises 4 FETs in a 2×2 array. 19 . The biosensor of claim 1 , wherein the multiplexed array comprises 9 FETs in a 3×3 array. 20 . The biosensor of claim 1 , wherein the 2D material includes graphene, MoS2, hBN, WS2, WSe2, PtS2, and/or PtSe2, a combination thereof or the like. 21 - 27 . (canceled)
Coronaviridae, e.g. avian infectious bronchitis virus · CPC title
Orthomyxoviridae, e.g. influenza virus · CPC title
Viruses · CPC title
Electrodes · CPC title
specially adapted for biomolecules, e.g. gate electrode with immobilised receptors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.